Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bionomy Health vs Eve

Bionomy Health
Graded #71

Higher grade

vs+7.599999999999994
Eve
Graded #212

Lower grade

The verdict

Bionomy Health takes it — 73.6/100 to 66/100.

Bionomy Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bionomy Health is a physician-led, direct-to-consumer men's telehealth brand offering compounded GLP-1 weight-loss medication alongside testosterone, peptides, and longevity protocols.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBionomy Health +14
68
54
Dose & formulationEve +3
85
88
Clinical oversightEve +1
78
79
Labs & monitoringEven
52
52
FulfillmentBionomy Health +27
94
67
Contract termsBionomy Health +20
61
41
Bionomy Health · left barEve · right bar

The numbers

MetricBionomy HealthEve
WeighScore73.6/10066/100
GradeCC
Scorecard rank#71#212
Semaglutide$189/mo$195/mo (compounded)
Tirzepatide$249/mo$195/mo (compounded)
Coverage48 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Bionomy Health

Graded #71 · C

Strengths

  • Offers both compounded semaglutide (189/mo) and tirzepatide (249/mo) with pay-per-prescription pricing and no subscription
  • Physician-led with a free, physician-reviewed intake before you pay anything
  • Fills through LegitScript-certified compounding pharmacies Strive and Absolute; available in 48 states
  • Pairs GLP-1 protocols with muscle-preserve supplements and a written training note to protect lean mass

Where it loses points

  • Men's health brand, so the site framing and protocols are geared to men rather than a general audience
  • New brand launched in 2026 with limited independent reviews and track record
  • Not available in Alaska or Hawaii; compounded medications are not FDA-approved
Eve

Graded #212 · C

Strengths

  • Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
  • Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
  • LegitScript Certified with a verifiable ID
  • Publishes the FDA compounded-medication disclaimer
  • Oral sublingual semaglutide offered alongside injectable

Where it loses points

  • Full states-served list not disclosed publicly
  • 503A pharmacy partner not named, and 503A vs 503B status not specified
  • Named medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed
  • Governing law / arbitration venue not stated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard